<DOC>
	<DOCNO>NCT00002260</DOCNO>
	<brief_summary>To characterize pharmacokinetics orally administer FLT ( liquid formulation ) single dos feed fast state ; assess effect food oral bioavailability FLT</brief_summary>
	<brief_title>An Open-Label , Crossover Study Assess Effect Food Oral Bioavailability Pharmacokinetic Profile 3'-Deoxy-3'-Fluorothymidine ( FLT ) Asymptomatic Human Immunodeficiency Virus ( HIV ) -Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Alovudine</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<criteria>Inclusion Criteria Patients must : Positive ELISA test confirm Western blot analysis . Asymptomatic . Willing sign inform consent . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Oral candida infection document morphology response antifungal therapy within two month prior study entry . Oral hairy leukoplakia time prior entry . Temperature &gt; 37.8 C. Any malignancy cutaneous basal cell carcinoma cervical carcinoma situ . Significant chronic underlie medical illness would prevent continuous participation clinical trial . Unwilling sign inform consent . Zidovudine induce hematological toxicity . Prior Medication : Excluded : Therapy antiretroviral drug immunomodulators within seven day entry . Therapy investigational drug precede 30 day . Patients may : Oral candida infection document morphology response antifungal therapy within two month prior study entry . Oral hairy leukoplakia time prior entry . Temperature &gt; 37.8 C. Any malignancy cutaneous basal cell carcinoma cervical carcinoma situ . Significant chronic underlie medical illness would prevent continuous participation clinical trial . Unwilling sign inform consent . Zidovudine induce hematological toxicity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1992</verification_date>
	<keyword>Biological Availability</keyword>
	<keyword>alovudine</keyword>
	<keyword>Food</keyword>
</DOC>